Long Non-Coding RNAs as Novel Biomarkers and Therapeutic Targets in Pediatric Leukemia |
New York University School of Medicine / Iannis Aifantis, PhD |
Innovation Grants |
2017 |
New York |
Alternative Splicing in the Pathogenesis of Acute Lymphoblastic Leukemia |
Children's Hospital of Philadelphia / Andrei Thomas-Tikhonenko, PhD |
Innovation Grants |
2017 |
Pennsylvania |
Targeting BRD9 in Sarcoma |
Dana-Farber Cancer Institute / Scott Armstrong, MD/PhD |
Innovation Grants |
2017 |
Massachusetts |
Characterization of Novel OTX2-semaphorin Gene Signaling Pathways Regulating the ‘Grow and Go’ Arms of Highly Aggressive Medulloblastomas |
University of Manitoba / Tamra Werbowetski-Ogilvie, PhD |
Innovation Grants |
2017 |
Manitoba |
Development of Nanoparticle-Encapsulated Chemo/Radio-Sensitizers for Intrathecal Delivery |
Yale School of Medicine / Ranjit S. Bindra, MD/PhD & Mark Saltzman, PhD |
Innovation Grants |
2017 |
Connecticut |
Targeting Pediatric Brain Tumors Using PTPmu Nanochains with Radiofrequency-Releasable Therapeutics |
Case Western Reserve University / Susann Brady-Kalnay, PhD & Efstathios Karathanasis, PhD |
Innovation Grants |
2017 |
Ohio |
Genome-Wide 5hmC Profiling of Neuroblastoma Tumors and Patient Cell-Free DNA |
University of Chicago / Susan Cohn, MD & Chuan He PhD |
Innovation Grants |
2017 |
Illinois |
Predictive Modeling of MDS Disease Progression From Inherited Bone Marrow Failure Syndrome Using Novel Branching Process and Next Generation Sequencing to Improve Patient-Specific Survival |
Cleveland Clinic Foundation / Seth Corey, MD & Marek Kimmel, PhD |
Innovation Grants |
2017 |
Ohio |
Defining the Cell Surface Landscape of Diagnostic and Relapsed Neuroblastoma: Immunotherapeutic Target Identification |
Children's Hospital of Philadelphia / Sharon Diskin, PhD |
Innovation Grants |
2017 |
Pennsylvania |
Targeting Metabolic Vulnerabilities in ETP-ALL |
Columbia University / Adolfo A. Ferrando, MD/PhD |
Innovation Grants |
2017 |
New York |